A suspension may be flocculated using a water soluble substantially linear polymer having a single point intrinsic viscosity above 3 and that is a copolymer of two or more ethylenically unsaturated monomers including at least 0.5% by weight of monomer carrying pendant hydrophobic groups. The cationic polymers are novel. Preferred polymers are those in which the hydrophobic group is introduced as an allyl ether.

This invention relates to a furniture polish comprising a paraffin wax and a microcrystalline wax, preferably in combination wit beeswax and a silicon oil. An organic solvent and water are present, and there may additionally be a surfactant and, in aerosol can applications, a propellant. The polish gives good gloss without tendency to smearing and good resistance to water damage.

This invention relates to compounds, pharmaceutical compositions, and methods of using the disclosed compounds for inhibiting PARP.

A substituted polysaccharide comprising .beta..sub.1-4 linkages having covalently bonded on the polysaccharide moiety thereof, at least one deposition enhancing group which undergoes a chemical change in water at a use temperature to increase the affinity of the substituted polysaccharide to a substrate, the substituted polysaccharide further comprising one or more independently selected silicone chains.

Novel non-coding sequences isolated upstream of the human IRS-2 gene are disclosed as markers for the prediction and/or diagnosis of IRS-2 related metabolic disorders or diseases, such as diabetes. The sequences also fuction as markers in a method and assay for evaluating the insulin regulating, i.e. insulin sensitizing or inhibiting properties of drug candidate substances, e.g. a method and assay for high throughput screening. The sequences and/or information derived therefrom can also be used ...

A system and process for ensuring the smooth flow of electronic ink is described. Dynamic rendering is give priority over other event handlers. Priority may be the use of one or more queues to order when events occur and may be performing dynamic rendering prior to other steps.

A composition containing (i) an anti-microbial agent that comprises a polymeric biguanide, either alone or in combination with at least one other microbiologically active component and (ii) a basic co-polymer of the Formula (1): [A].sub.m-[B].sub.n-[D].sub.y.sub.q. Formula (1)

A composition containing (i) an anti-microbial agent that comprises a polymeric biguanide, either alone or in combination with at least one other microbiologically active component and (ii) an amphoteric co-polymer of the Formula (1): ##STR00001##

Compounds of the general formula (I): ##STR00001## wherein R.sup.1, R.sup.2, R.sup.3 and R.sup.4 are as described in the specification. Further included are pharmaceutical compositions comprising the compounds, processes for their preparation, as well as the use of the compounds for the preparation of a medicament which particularly acts on the central nervous system, particularly for use as anti-obesity agents.

The invention relates to compounds of the general formula (I) ##STR1## wherein R1, R2 and R3 are as described in the specification, which compounds are ligands to the serotonin 5-HT.sub.2c receptor.